DNA damage, Mitomycin, cell senescence
To determine the cause for the observed changes in the cell cycle distribution of A549 cells following 24 h continuous treat-ment with MMC, a pulse of the DNA precursor EdU was added to the cultures for 1 h prior to fixation. Cells treated with 0.1–2.0 μg/ml MMC showed a dramatic decrease in EdU fluorescence, indicating they were replicating DNA at a very slow rate and, thus, traversing S phase extremely slowly (Fig. 1D). Analysis also revealed that 75–83% of cells considered to be in S phase based on DNA content did not incorporate detectable EdU following treatment with 0.5–2.0 μg/ml MMC which meant those cells had stopped progressing through S phase.
Long-term treatment with low MMC concentration. Since exposure to MMC concentrations of 0.1 μg/ml or higher blocked cells in S phase or prevented their entry into S phase, A549 cells were exposed to prolonged treatment at lower drug concentra-tions. Thus, the cells were treated continuously with 0.01–0.05 μg/ml MMC for 3 or 6 d. The treatment for 3 d led to a decrease in the proportion of G1 phase cells and an increase in G2M phase cells as well as an accumulation of cells with a DNA content above a DNA index of 2.0 (DI > 2.0) (Fig. 2A). The accumula-tion of DI > 2.0 cells was even more pronounced following 6 d continuous treatment with 0.01–0.02 μg/ml MMC (Fig. 2A). It is important to note that these higher DNA ploidy cells are always present in control cultures of A549 cells, but since they make up a small percentage of the total population, their presence is often ignored. At present, we define the cells with a DI = 1.0 as G1 (dip-loid) cells, cells with a DI = 2.0 as G2M phase diploid cells plus G1 cells of the higher ploidy (G1T; tetraploid) and cells with a DI = 4.0 as G2M tetraploid cells (G2MT) plus possibly G1 octoploid cells (G1O). Each of the different DNA ploidy populations have S phase cells which were designated as S for the diploid and ST for the tetraploid populations, respectively.
The percentage of cells at these higher DNA ploidies (DI = 2.0 and 4.0) increased after treatment with 0.01–0.02 μg/ml MMC for 3 or 6 d with a concomitant decrease in proportion of G1 phase cells (DI = 1.0) (Fig. 2A and B). Treatment with 0.05 μg/ml MMC, however, did not give rise to a significant number of cells at a DI = 4.0; the vast majority of cells accumulated in a population with a DI = 2.0 (Fig. 2A and B). Accumulation of G2M and G2MT cells combined with the evidence of suppression of DNA replication (Fig. 1D) indicate that following treatment with 0.01 and 0.02 μg/ml MMC, the cells were still moving through the S and ST phase, albeit at a very slow pace.
When cells with a DI = 2.0 were visualized by LSC, it was clear that nearly all cells (> 90%) contained a single nucleus with increased nuclear area (Fig. S1), indicating that they entered a higher ploidy by the process of endoreduplication rather than endomitosis.
Persistent replication stress is known to induce cell senes-cence.19-21 It is quite evident that at MMC concentrations of 0.01 and 0.02 μg/ml, some cells were replicating DNA at a mini-mal rate and thus were subjected to persistent replication stress. Attempts have been made, therefore, to determine whether these cells were undergoing senescence. One of the biomarkers of DNA replication stress and induction of senescence is the presence of DNA damage signaling, of which phosphorylation of histone
H2AX on Ser139 (γH2AX) is a prominent feature.19,20 Therefore, we tested for the induction of this biomarker in cells subjected to 3 and 6 d exposure to 0.01 and 0.02 μg/ml MMC. Induction of γH2AX showed a concentration-dependent increase at 3 d, which remained constant from 3 to 6 d (Fig. 3). The mean level of γH2AX fluorescence for all cells increased about 2-fold over the control, untreated cells following treatment with 0.01 μg/ml MMC, and to greater than 3.5-fold when treated with 0.02 μg/ml MMC. There was no significant increase in the percentage of cells positive for activated caspase-3 following treatment with either concentration of drug for up to 6 d, which otherwise would indicate the induction of apoptosis (Fig. S2).
Induction of senescence-associated β-galactosidase activ-ity is considered the most specific marker of cell senescence.22 Cells exposed to low concentrations of MMC were tested for the expression of this biomarker. It is quite evident that β-galactosidase activity was dramatically increased in the MMC-treated cells (Fig. 4A). Their cellular and nuclear size was also markedly enlarged. Another characteristic feature of the MMC-treated cells was low cell density at confluence (Fig. 4A), which is also typical of senescence (5). While only a small percentage of cells were positive for β-galactosidase following 3 d of treatment, over 90% were β-galactosidase-positive after 6 d (Fig. 4B). These cells also expressed p21WAF1 (Fig. 5A), a cyclin-dependent kinase inhibitor that is associated with cell senescence.23,24 Similar to β-galactosidase, there was no significant increase in p21WAF1 seen following 3 d treatment, while there was a 10- to 15-fold increase after 6 d (Fig. 5B).
We have recently established a method to quantitatively assess the degree (“depth”) of cell senescence through morphometric analysis of their characteristic changes in nuclear morphology.25 The method is based on analysis of the ratio of the local nuclear DNA staining intensity (maximum pixel of fluorescence inten-sity of a DNA-associated fluorochrome, mp) to nuclear area (mp/area), assessed by imaging cytometry.25 The decrease in this ratio, which was defined as the cell senescence index (SI), is a sensitive and quantitative reporter of the “flattening” of the cell on the surface of the slide, resulting in the DNA being spread out over a larger nuclear area.25 The data show that treatment of cells with either 0.01 or 0.02 μg/ml MMC for 3 or 6 d led to a significant decrease in this ratio which was distinctly more pronounced at 6 d compared with 3 d of treatment (Fig. 6).
Even though it appeared that most cells had entered senes-cence and were present at DI = 1.0, 2.0 and 4.0 ploidy levels, there were still a small number of cells present in S phase, and it was important to determine whether these cells continued to replicate DNA. Therefore, a 1 h pulse of EdU was given to cells treated for 6 d with either 0.01 or 0.02 μg/ml MMC just prior to cell fixation. The total percentage of cells incorporating EdU dropped from 42.7% in the control to 7.6% and 3.7% after 6 d of treatment with 0.01 and 0.02 μg/ml MMC, respectively (Fig. 7A). Due to the accumulation of cells at a higher DNA ploidy, there were two separate S phases to be considered; cells cycling between a DI = 1.0 and 2.0 (S) and cells cycling between a DI = 2.0 and 4.0 (ST). Treatment with either MMC concentration led to a decrease in the percentage of both S and ST phase cells that
Volume 11 Issue 16
3134 Cell Cycle
热门文档